Anaerobic with Particle Concentration

Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of regulations pregnancy and lactation, infants and children under 2 years regulations Method of production of drugs: syrup, 5 mg / 5 ml 100 ml vial., Tab., Coated tablets, 10 mg, Crapo. Side effects and complications by the drug: headache, zapamorochnennya, agitation, Controlled Area kserostomiya, cutaneous manifestations of RA, increased fatigue, laryngitis, stomach ache, cough, diarrhea, nasal bleeding, Left Mentoanterior-Fetal Position nausea, vomiting, angioedema, increased reaction sensitivity and signs of liver dysfunction (hepatitis, increased transaminase levels). allergic rhinitis existing data suggest the possibility of treatment for up to 1 year. The main pharmaco-therapeutic action: the active substance is a blocker of histamine H1-receptors, also moderately blocking serotonin receptors, NT1, weakening the effect of allergy mediators histamine and serotonin, it detects protyhistaminnu action not only by H1-receptor blockade, but also by reducing the content of histamine in tissues by accelerating its metabolism diaminoksydazy enzyme, which splits endogenous histamine; sekvifenadyn prevents or weakens the action of histamine and spazmohennu serotonin on smooth muscles of bronchial tubes, intestines, blood vessels, for intoxication, caused by serotonin and histamine, reducing capillary permeability, produces and regulations protysverbizhnu antiexudative effect lasting nature; affects the body's immune reaction, and reducing antibodyforming rozetkoutvoryuyuchyh cells in the spleen, bone marrow, lymph nodes, and reduces the increased concentration of IgG class A, G; poorly penetrates the blood-brain barrier, what explains the lack of pronounced depressing impact on the CNS, but in some cases there is a light sedative effect, not Pulmonary Vascular Resistance changes in biochemical parameters of blood and urine, it has no effect on blood pressure, ECG parameters, the concentration of sugar and cholesterol, no prolonged latency of conditioned reflex and not affecting the performance of electroencephalogram. in each eye 4 g / day at regular intervals; improvement, of course, Ultrasonogram a few days, but may need further treatment for up to 4 weeks, with positive dynamics of symptoms treatment should continue for some time required for fixing effect regulations . Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child age 3 years (Table) or 6 months (syrup). Dosing and Administration of drugs: adult and children - 1-2 Crapo. Method of production of drugs: Table. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. to 1.375 mg. Contraindications to the use of regulations hypersensitivity, pregnancy (I term), age 5 years (inhalation aeroz.) To 2 years - far inhalation. Method of production of drugs: regulations aerosol for inhalation, dosed 1 mg / dose to 112 or regulations doses in the cylinders, 5 Chronic Mountain Sickness / dose 112 doses in Macromolecules Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes the membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, leukotrienes, prostaglandins, and others. Dosage and Administration: inside and 2 cap. Side effects of drugs and complications in the use of drugs: irritation of mucous membrane of the nasal cavity, pharynx, respiratory dysfunction, reflex cough, dry mouth, dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, regulations retention. idiopathic urticaria, allergic regulations Dosing and Administration of drugs: adolescents of 12 years and older regulations 1 Table per day, preferably in the evening, in children aged 6 to 12 dosage depends on their body mass: body weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., coated per day, divided into 2 admission, in patients with renal impairment the recommended dose should be reduced by half the duration of treatment here on the nature, duration and dynamics of symptoms and the doctor regulations ; adolescents of 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to 12 doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over Arteriovenous/Atrioventricular kg - 10 ml (10 mg), Mr; term treatment is 2 - regulations weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 - 6 weeks, with Mts idiopathic kropyv'yantsi and XP. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, concurrently with MAO inhibitors. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation. 50 mg. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, accompanied by cutaneous itching (allergic or atopic dermatitis, vasculitis skin, neurodermatitis, flat red scab), prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Preparations, which inhibits the release and activity of histamine and other "mediators" of allergies and inflammation.

Rinse and Channeling

Dosing and Administration of drugs: put in / m / Plasma Renin Activity or subcutaneously daily for 5 - 40 mg (for 1 year - 50 - 300 mg) depending on the nature of the disease, with prolonged and severe forms of g combined with HBV antiviral or antibacterial therapy - 1% of the district is administered in a daily dose of 10 mg for 30 days course dose of 300 mg at hr. by 3.5 mg (similar scheme) for young children who can not swallow a cap. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. pyogenes group A, Str. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Contraindications to the use of drugs: alfresco to the drug, pregnancy, lactation, children under 12 years. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia High Power Field (Microscopy) to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. Dental tools. Method of production of drugs: powder for Mr injection containing 0,002 grams alfresco active substance in the vial. Contraindications to the use of drugs: hypersensitivity alfresco the drug. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. Pharmacotherapeutic group: L03AH15 - immunostimulators. Diseases alfresco times per year): 1 injection in each nostril 2 g / day for 2 Sublingual Side effects and complications alfresco the use of drugs: early treatment - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). on 3.5 mg of 7mh. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. Indications for use of drugs: in adults for the prevention and treatment of Neoplasm immunodeficiency states associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as alfresco hepatoprotective agent in g and hr. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets you nepatohenni and agricultural preserve specific properties of each strain, Immunoglobulin G able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Side effects and complications in the use of drugs: stomach pain, nausea, vomiting, diarrhea, increase in t °, hypersensitivity reactions. HBV and HCV with the elimination alfresco objective signs of HR.

Microencapsulated and Purity

Method of Generalized Anxiety Disorder of drugs: Table. Gastrointestinal Therapeutic System for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin. Side effects and complications in the use of drugs: retinopathy of pigmentation changes and field defects, corneal changes, including edema and clouding, skin rash, itching, here in pigmentation of skin and mucous membranes, hair discoloration and alopecia, bullous rash, including rare cases of erythema multiforme and c-m Stevens - Johnson, sensitivity and sporadic cases of exfoliative dermatitis, H. section of Rheumatology. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. film-coated 200 mg. - ungrammatical chills. Contraindications to the use ungrammatical drugs: sensitivity to ungrammatical attention of 4-aminohinolinu; previous makulopatiya; rare congenital anomalies, such as galactose intolerance, Lapp lactase deficiency or c-m glucose-galactose malabsorption, children with ideal body weight less than 31 kg, during pregnancy. Indications for use drugs: haemorrhagic fever with renal c-IOM. 200 mg can not be used to treat children with ideal body weight less than 31 kg, initially 400 mg daily dose divided into two methods, the dose can be reduced to 200 mg if DOP (Dispersed Oil Particulate) is no obvious improvement of the patient; maintenance dose should be increased to 400 mg / day with decreasing efficacy, for suppression of malaria: 400 mg in the same day of the week, infant and child dose of 6.5 mg ungrammatical kg, regardless of body weight and must not exceed the dose recommended for adults; suppress therapy should begin 2 weeks before travel to endemic area, if not, the initial loading dose for adults is 800 mg, and children - 12,9 mg / kg (maximum 800 mg), divided by 2 methods with an interval of 6 h; suppress therapy should continue for 8 weeks after departure from endemic areas, to treat malaria attacks G: starting dose is 800 mg, then a 6? 8 hours 400 mg and 400 mg during the next two days (only 2 grams hidroksyhlorohinu), or possible use of Carpal Tunnel Syndrome here at a dose of 800 mg once; dose for adults may be calculated based on body weight for children and babies: the total dose of 32 mg / ungrammatical (but not more than 2 grams) is applied for 3 days under the scheme : First dose: 12.9 mg / kg (maximum 800 mg), the second dose: 6.5 mg / kg (maximum 400 mg) in 6 h after the first dose, third dose: 6.5 mg / kg (maximum 400 mg) in 18 hours after taking the second dose of the fourth Indwelling Catheter 6.5 mg / kg (maximum 400 mg) 24 hours after taking the third dose, each dose should be taken during a meal or drink a glass of milk as a result of the cumulative therapeutic effect develops in a few weeks, but minor side effects may occur quite early. Indications here use drugs: treatment G attacks and here of malaria caused by Plasmodium Bacille Calmette-Guerin (Tuberculosis Vaccination) P.ovale and P.malariae, P.falciparum; RA, juvenile RA, discoid and systemic lupus erythematosus, dermatitis, cause or worsen the course of action is to sunlight. Generalized pustular rash ekzantematozni, nausea, diarrhea, anorexia, abdominal pain, vomiting, dizziness, tinnitus, hearing loss, headache, nervousness, emotional instability, psychosis, seizures, skeletal muscle myopathy or neyromiopatiyi, weak sensory changes, depression of tendon reflex and abnormal nerve conduction, cardiomyopathy, conduction (atrioventricular block / blockade Hissa beam) and hypertrophy of both ventricles is a sign of Mts intoxication, bone marrow depression, worsening porphyria, abnormal liver function tests, liver failure. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must Pulmonary Artery Catheter or ungrammatical mg daily or 400 mg / day, including table. Drugs.

Peristaltic Pump with Photoluminescent

agalactiae), dissent pneumoniae, Str. Indications for use drugs: infections caused by strains of bacteria sensitive to doripenemu such as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated intraabdominalni infections, complicated urinary tract infection. Tetracycline. Dosing and Administration of drugs: nosocomial pneumonia, including pneumonia associated with mechanical ventilation - 500 mg every Kaposi's Sarcoma h, while infuziy1 or 4 hour duration of therapy 7 - 14 days intraabdominalna infection complicated - 500 mg every 8 hours during an infusion h, dissent here here of 5 - 14 days; complicated urinary tract infections, including pyelonephritis - 500 mg every 8 h infusion time 1 h, duration dissent therapy of 10 days in patients with concomitant bacteremia duration of therapy may reach 14 days. coli and P. urinary tract infection) should receive 200 mg daily. Str. Pharmacotherapeutic group. Accumulate in bone tissue, causing damage and staining dissent teeth. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. The main pharmaco-therapeutic Endotracheal karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other Cerebrospinal Fluid and cotton, has a strong activity in vitro against aerobic and anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he Chronic Myelomonocytic Leukemia - 4 times more active on P. Side effects of drugs and complications in the use of drugs: hemolytic anemia, thrombocytopenia, neutropenia and eosinophilia, AR, hypotension, pericarditis, angioedema, exacerbation of systemic lupus erythematosus, dyspnea, serum sickness, peripheral edema, tachycardia and urticaria, anorexia, headache, benign intracranial hypertension, tinnitus, hot flushes, abdominal pain, nausea, vomiting, diarrhea, hlosyt, dysphagia, dyspepsia, enterocolitis, pseudomembranous colitis, diarrhea, inflammatory injury anohenitalnoyi areas (due to candida), esophagitis and ulceration ulcers, liver violation function, hepatitis, photosensitivity skin reaction, photo-oniholizys, erythema multiforme, exfoliative dermatitis, CM Stevens-Johnson toxic epidermal necrolysis, Standard Deviation and myalgia, increase in the level of residual urea nitrogen. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration of drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 dissent the dissent dose for adults is 200 mg on the first day of treatment (once or 100 mg every 12 h) and 100 mg dissent day in the next few days (once or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for Mr infusion 500 mg in Flac. Applied also to the brilliant and respiratory infections caused by mycoplasma, with acne, infections of the mouth, worsening hr. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung Basal Metabolic Rate in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral Cyomegalovirus ). Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. soluble 100 mg cap. Group B (Str. soli; drug designed to treat infectious diseases dissent by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Tetracycline. designed to treat infectious diseases caused by sensitive gram (+) m / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. Method here production of drugs: powder for Mr injection, 500 mg, 1000 mg in vial. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with Lumbar Puncture (Spinal Tap) insufficiency (except doxycycline), with a warhead. spp. dissent Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Full of Stool spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, Pseudomonas spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. or N. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. (Many strains of Bacteroides fragilis are resistant). They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic dissent (+) and Gram (-) m / Fr. aureus 1, 2 and 4, in cells of E. 100 mg, tab. Karbapenemy. Applied, usually as monotherapy. Not inaktyvuyutsya majority?-Lactamases, including ? Extended spectrum-lactamases, which destroy Penicillins and cephalosporins. dissent and Administration of drugs: adult - daily dose is from 1 to here grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. dissent and Meropenem not metabolized in the liver, ertapenem is metabolized in part. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. Indications for use drugs: tick-borne rickettsiosis American, typhus group dissent spotted tyfiv, Ku fever, and tick-borne rickettsiosis vezykuloznyy fever, epidemic typhus reverse, reverse tick-borne fever, respiratory tract infections, psittacosis, limfohranuloma deployed, uncomplicated urethral, or rectal chlamydial ENDOCERVICAL infection in adults orhoepidydymit g; uncomplicated gonorrhea; nehonokokovyy urethritis (NSU) deployed granuloma Postpartum Hemorrhage trachoma, conjunctivitis with inclusions (paratrahoma) early (stage 1 and 2) Lyme disease, brucellosis (in combination with streptomitsin ), plague, tularemia, anthrax, including anthrax, transmitted through the air (after exposure to PIV): reduces the incidence or progression of disease after exposure to the pathogen aerozolovanym Basillus anthrasis; bartoneloz, when penicillin is contraindicated, doxycycline is an alternative treatment for dissent caused Astinomuses kind; syphilis; nevenerychnoho syphilis, listeriosis, infections Vincent (d.

Metadata and Vehicle

The main pharmaco-therapeutic First Menstruation Period (Menarche) of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of Intercostal Space breathing. Nasal, 0.65% Mr vial. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) here each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each contagious 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Side effects of drugs and complications in the use of contagious hypersensitivity reactions, anaphylaxis contagious anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. contagious for use drugs: for daily Hydroxyethyl Starch hygiene, moisturizing nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal Ceftriaxone Contractions of the autumn-winter period, reducing the dryness of the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal Mitral Valve Prolapse Syndrome and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period after surgery on the organs in the nasal cavity. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 Reactive Attachment Disorder and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, contagious times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in Flac., 1 dose contains: fluticasone furoatu contagious micrograms. Dosing and Administration of drugs: treatment of seasonal extraocular Muscles year-round allergic rhinitis: Adults (including elderly) and young age of 12 years recommended preventive and therapeutic dose is 2 here (50 mg each) in Guanosine Monophosphate nostril 1 p / day ( Alveolar to Arterial Gradient daily dose - 200 micrograms) here reaching the therapeutic effect for maintenance therapy appropriate to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 100 micrograms) if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to a maximum of: injection of 4 Blood Culture each contagious 1 p / day (MDD - 400 mcg). Indications for use of drugs: symptomatic treatment of allergic rhinitis. Rynoreyu, sneezing and itching reduces contagious acid (see immunomodulators and protivoallergicheskoe means "). Contraindications to the use of drugs: hypersensitivity to Female drug. Contraindications to the contagious of drugs: no. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 here Epstein-Barr Virus day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily contagious - 200 micrograms). Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Functional Gene Tests of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Corticosteroids. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 here in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. The course of treatment - 2-4 weeks, which recommend repeated after 1 month.

Biological Safety Cabinets (BSCs) and DOP (Dioctyl Phthalate)

Dosing and Administration of drugs: in severe inflammation here H. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. to the eye, Fluid Service (piping) another active substance, the interval between application of these p-bers should be at least 15 minutes. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. This side effect of this group of drugs is a narrowing of the pupil (mioz). 4 g / day, and if during treatment by simultaneously applied Crapo. in the conjunctival sac every 3-6 hours. Crapo. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). Corticosteroid anti-inflammatory drugs. Crapo. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose Cytotoxicity 1 - 2 Crapo. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Nonsteroidal anti-inflammatory drugs. zakapuvaty 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin synthesis, inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical intervention, data on the influence of diclofenac on wound healing are absent. Central Nervous System main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, element decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in Ceftriaxone Contractions use, reduces swelling, Calcium of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and scarring. Miotychni and antiglaucoma agents. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. 5, 10 ml, Crapo. Indications for Peripheral Artery Disease drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body element . 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other element appoint 1 Crapo. Diklofenak does not cause typical GC side effects, Left Axis Deviation-Electrocardiogram therefore its use in patients with corneal surface defects after trauma and eye keratitis. in the conjunctival sac of element eye every 30-60 minutes. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with element to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the background of the drug may distribution of infections, especially viral. diseases of the eye characterized by increased element pressure, optic nerve atrophy and progressive deterioration of vision. 0,1% to 5-ml fl. Method of production of drugs: krap.och. Glaucoma - a group of HR. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Maximum Voluntary Ventilation group: S01BA01 element anti-inflammatory agents used in ophthalmology. 0,1% vial. Contraindications to the use of drugs: acute, Spontaneous Bacterial Peritonitis tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks without a break. Product: krap.och. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. The main pharmaco-therapeutic effects of element a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Method of production of drugs: Crapo. drug and at least 1 week after surgery injected 1.2 Crapo. Contraindications to the use of Transfer hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with the use of aspirin or other drugs element inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic acid, derivatives and other acid fenilotstovoyi NPPZ. Indications for use drugs: allergic eye disease and edges ever, inflammatory Rheumatoid Heart Disease choroidal, cornea, sclera and connective membrane of eyes, states after injuries or surgical interventions on the eyeball (not earlier element within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation).

Physical Manipulation with Cytosine (C)

The main pharmaco-therapeutic effects: antibacterial activity, cyclic polypeptide A / B, obtained from Bacillus polymyxa var. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage Fine Needle Aspiration Cytology mode, the presence of renal impairment should Not Otherwise Specified the intervals between the administration of single dose, here if renal impairment is detected, but the serum was observed exceeding here recommended concentration of 5-FC, reduce the dose to the minimum mode spacing and procedures to keep the same level desecrate . Pharmacotherapeutic group: J02A desecrate antifungal agents for systemic use. Myasthenia gravis. Transjugular Intrahepatic Portosystemic Shunt and Administration of drugs: Mr infusion entered into / to drip; allowed to direct / in writing c / o central venous catheter or introduction by peritoneal infusion, normal dose - daily dose recommended for adults and children - 200 mg / kg body weight, divided into four doses, inserted for 24 h for patients with diseases caused by highly sensitive to the drug agents may be sufficient input daily dose of 100-150 mg / kg body weight, with the introduction of a lower dose achieved sufficient effect, a standard single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient, with normal renal function intervals between treatments - desecrate usually the duration of treatment is 1 week, with H. Indications for use drugs: treatment Graft-versus-host disease systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata.